SK bioscience Co.,Ltd. (KRX: 302440)
South Korea
· Delayed Price · Currency is KRW
48,800
+800 (1.67%)
Feb 5, 2025, 12:04 PM KST
SK bioscience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Feb '25 Feb 4, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 3,839,017 | 5,528,451 | 5,643,627 | 17,212,500 |
| Market Cap Growth | -18.12% | -2.04% | -67.21% | - |
| Enterprise Value | 2,704,232 | 4,326,779 | 4,104,200 | - |
| Last Close Price | 49000.00 | 72000.00 | 73500.00 | 225000.00 |
| PE Ratio | - | 247.72 | 46.09 | 48.47 |
| Forward PE | - | - | 24.69 | 23.37 |
| PS Ratio | 18.70 | 14.96 | 12.36 | 18.53 |
| PB Ratio | 2.19 | 3.24 | 3.24 | 10.75 |
| P/TBV Ratio | 2.50 | 3.27 | 3.25 | 10.78 |
| P/FCF Ratio | - | - | - | 34.87 |
| P/OCF Ratio | - | 188.39 | - | 32.08 |
| EV/Sales Ratio | 13.43 | 11.71 | 8.99 | - |
| EV/EBITDA Ratio | - | 189.96 | 28.85 | - |
| EV/EBIT Ratio | - | - | 35.68 | - |
| Debt / Equity Ratio | 0.12 | 0.01 | 0.07 | 0.07 |
| Debt / EBITDA Ratio | - | 0.90 | 0.80 | 0.22 |
| Debt / FCF Ratio | - | - | - | 0.22 |
| Asset Turnover | 0.10 | 0.19 | 0.21 | - |
| Inventory Turnover | 1.20 | 1.70 | 1.35 | - |
| Quick Ratio | 10.82 | 9.56 | 4.13 | 3.68 |
| Current Ratio | 11.69 | 10.20 | 4.69 | 4.00 |
| Return on Equity (ROE) | -2.51% | 1.30% | 7.33% | - |
| Return on Assets (ROA) | -3.03% | -0.38% | 3.38% | - |
| Return on Capital (ROIC) | -3.27% | -0.42% | 4.04% | - |
| Return on Capital Employed (ROCE) | - | - | 6.53% | 28.74% |
| Earnings Yield | -1.13% | 0.40% | 2.17% | 2.06% |
| FCF Yield | -4.79% | -0.26% | -3.51% | 2.87% |
| Buyback Yield / Dilution | 0.28% | 0.01% | -4.32% | - |
| Total Shareholder Return | 0.28% | 0.01% | -4.32% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.